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Background: Bladder cancer is a common malignancy affecting the genitourinary system that represents 
the fifth most common cancer in the world. Transitional cell carcinoma (TCC) represents 95% of these 
tumours. Vinflunine (VFL) is a microtubule-targeting drug that suppresses microtubule dynamics, 
showing anti-metastatic properties both in vitro and in living cancer cells. An increasing body of evidence 
underlines the influence of the microtubules dynamics on the cadherin-dependent cell–cell adhesions. In 
this report, we investigate the role of VFL on cell–cell contacts in bladder epithelial tumour cells. 
Methods: Human bladder epithelial tumour cell lines HT1376, 5637 and UMUC3 were used to analyse 
cadherin-dependent cell–cell adhesions under VFL treatment. VFL effect on growth inhibition was 
measured by using a MTT colorimetric cell viability assay. Western blot, immunofluorescence and 
transmission electron microscopy analyses were performed to assess the roles of VFL effect on cell–cell 
adhesions, epithelial-to-mesenchymal markers and apoptosis. The role of the proteasome in controlling 
cell–cell adhesion was studied using the proteasome inhibitor MG132. 
Results: We show that VFL induces cell death in bladder cancer cells and activates epithelial 
differentiation of the remaining living cells, leading to an increase of E-cadherin-dependent cell–cell 
adhesion and a reduction of mesenchymal markers, such as N-cadherin or vimentin. Moreover, while E-
cadherin is increased, the levels of Hakai, an E3 ubiquitin-ligase for E-cadherin, were significantly 
reduced in presence of VFL. In 5637, this reduction on Hakai expression was blocked by MG132 
proteasome inhibitor, indicating that the proteasome pathway could be one of the molecular mechanisms 
involved in its degradation. 
Conclusions: Our findings underscore a critical function for VFL in cell–cell adhesions of epithelial 
bladder tumour cells, suggesting a novel molecular mechanism by which VFL may impact upon EMT 
and metastasis. 
 
 
